LeMaitre Vascular

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. The company is listed on NASDAQ.
Burlington, US
Size (employees)
339 (est)
LeMaitre Vascular was founded in 1983 and is headquartered in Burlington, US

LeMaitre Vascular Office Locations

LeMaitre Vascular has offices in Burlington, Inzell, Chiyoda, Mississauga and in 4 other locations
Burlington, US (HQ)
63 Second Ave
North Melbourne, AU
36 Munster Terrace
San Giuliano Milanese, IT
86 Viale Leone Tolstoj
Madrid, ES
Plaza De España
Mississauga, CA
608 5915 Airport Rd
Inzell, DE
Otto Volger Str. 5 A/B 65843 Sulzbach/Ts

LeMaitre Vascular Data and Metrics

LeMaitre Vascular Financial Metrics

LeMaitre Vascular's revenue was reported to be $89.2 m in 2016

Revenue (Y, 2016)

89.2 m

Revenue growth (Y, 2015 - Y, 2016), %


Gross profit (Y, 2016)

62.9 m

Gross profit margin (Y, 2016), %


Net income (Y, 2016)

10.6 m

EBIT (Y, 2016)

16.3 m

Market capitalization (28-Jun-2017)

584.6 m

Closing share price (28-Jun-2017)


Cash (31-Dec-2016)

24.3 m
LeMaitre Vascular's current market capitalization is $584.6 m.
USDFY, 2013FY, 2014FY, 2015Y, 2016


64.5 m71.1 m78.4 m89.2 m

Revenue growth, %


Cost of goods sold

19.4 m22.7 m24.2 m26.2 m

Gross profit

45.1 m48.4 m54.2 m62.9 m

Gross profit Margin, %


Operating expense total

40.6 m42.1 m42.7 m46.6 m


4.5 m6.3 m11.5 m16.3 m

EBIT margin, %


Interest expense

12 k5 k5 k14 k

Interest income

4 k1 k13 k81 k

Pre tax profit

4.3 m6.3 m11.4 m16.2 m

Income tax expense

1.1 m2.4 m3.7 m5.7 m

Net Income

3.2 m3.9 m7.8 m10.6 m
USDFY, 2013FY, 2014FY, 2015FY, 2016


14.7 m18.7 m27.5 m24.3 m


3.2 m2.4 m3.6 m2 m

Current Assets

41.7 m48.6 m58.2 m59 m


5.8 m6.9 m7 m8 m


15 m17.3 m17.8 m23.4 m

Total Assets

70.5 m81.5 m90.7 m101.9 m

Accounts Payable

1.2 m1.1 m1.4 m1.2 m

Current Liabilities

10.2 m10 m10.4 m10.5 m

Additional Paid-in Capital

65.4 m75.4 m82.1 m85.4 m

Retained Earnings

(667 k)3.2 m8.2 m15.3 m

Total Equity

56.6 m68.2 m77.9 m87.5 m

Financial Leverage

1.2 x1.2 x1.2 x1.2 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

3.2 m3.9 m7.8 m10.6 m

Depreciation and Amortization

2.8 m3.3 m3.4 m3.6 m

Accounts Receivable

(1.2 m)(654 k)(1.9 m)(922 k)


(2.2 m)(2.7 m)608 k

Accounts Payable

861 k(1.1 m)2.6 m(103 k)

Cash From Operating Activities

5.4 m5.5 m11.4 m16.9 m

Purchases of PP&E

(2.7 m)(1.2 m)(2.3 m)(2.8 m)

Cash From Investing Activities

(6.2 m)(7.7 m)(3.5 m)(17.2 m)

Long-term Borrowings

(1.1 m)(1.1 m)(1.1 m)

Cash From Financing Activities

(961 k)6.7 m1.1 m(2.6 m)
Y, 2016

Financial Leverage

1.2 x

LeMaitre Vascular Market Value History

LeMaitre Vascular Online and Social Media Presence

LeMaitre Vascular Company Life and Culture

You may also be interested in